These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3379125)

  • 21. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria.
    Jensen T; Stender S; Goldstein K; Hølmer G; Deckert T
    N Engl J Med; 1989 Dec; 321(23):1572-7. PubMed ID: 2685599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of fish oil on metabolic parameters in patients with type 2 diabetes mellitus associated with dyslipidemia].
    Zák A; Zeman M; Tvrzická E; Stolba P
    Cas Lek Cesk; 1996 May; 135(11):354-9. PubMed ID: 8706072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus.
    Li SC; Liu YH; Liu JF; Chang WH; Chen CM; Chen CY
    Metabolism; 2011 Apr; 60(4):474-9. PubMed ID: 20580779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.
    Phillipson BE; Rothrock DW; Connor WE; Harris WS; Illingworth DR
    N Engl J Med; 1985 May; 312(19):1210-6. PubMed ID: 3990714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.
    Luo J; Rizkalla SW; Vidal H; Oppert JM; Colas C; Boussairi A; Guerre-Millo M; Chapuis AS; Chevalier A; Durand G; Slama G
    Diabetes Care; 1998 May; 21(5):717-24. PubMed ID: 9589230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.
    Friday KE; Childs MT; Tsunehara CH; Fujimoto WY; Bierman EL; Ensinck JW
    Diabetes Care; 1989 Apr; 12(4):276-81. PubMed ID: 2707115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercholesterolaemic effect of fish oil in insulin-dependent diabetic patients.
    Vandongen R; Mori TA; Codde JP; Stanton KG; Masarei JR
    Med J Aust; 1988 Feb; 148(3):141-3. PubMed ID: 3340028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
    Montori VM; Farmer A; Wollan PC; Dinneen SF
    Diabetes Care; 2000 Sep; 23(9):1407-15. PubMed ID: 10977042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis.
    Chen C; Yu X; Shao S
    PLoS One; 2015; 10(10):e0139565. PubMed ID: 26431431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fish oil-induced changes in apolipoproteins in IDDM subjects.
    Mori TA; Vandongen R; Masarei JR
    Diabetes Care; 1990 Jul; 13(7):725-32. PubMed ID: 2201495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish oil and glycemic control: importance of dose.
    Popp-Snijders C; Bilo HJ; Heine RJ
    Diabetes Care; 1990 Jan; 13(1):80-1. PubMed ID: 2298115
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of alpha-adrenergic blockade on blood pressure, glucose, and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Maruyama H; Saruta T; Itoh H; Koyama K; Kido K; Itoh K; Takei I; Kataoka K
    Am Heart J; 1991 Apr; 121(4 Pt 2):1302-6. PubMed ID: 1672575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes.
    Osei K; Falko J; Bossetti BM; Holland GC
    Am J Med; 1987 Aug; 83(2):249-55. PubMed ID: 3618627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoproteins and metabolic control in hypertensive type II diabetics treated with clonidine.
    Nilsson-Ehle P; Ekberg M; Fridström P; Ursing D; Lins LE
    Acta Med Scand; 1988; 224(2):131-4. PubMed ID: 3048053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnesium and ascorbic acid supplementation in diabetes mellitus.
    Eriksson J; Kohvakka A
    Ann Nutr Metab; 1995; 39(4):217-23. PubMed ID: 8546437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological effects of omega-3 fatty acids in diabetes mellitus.
    Malasanos TH; Stacpoole PW
    Diabetes Care; 1991 Dec; 14(12):1160-79. PubMed ID: 1773702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on the glycemic, lipid and blood pressure control of type 2 diabetes patients of Kerala.
    P SK; A M S
    Diabetes Metab Syndr; 2017; 11(4):231-235. PubMed ID: 27509820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma apolipoprotein B levels and blood hyperviscosity in non-insulin-dependent diabetic patients: role in the occurrence of arterial hypertension.
    Solerte SB; Fioravanti M; Patti AL; Fedele P; Schifino N; Melzi D'eril GV; Gorrini M; Ferrari E
    Acta Diabetol Lat; 1987; 24(4):341-9. PubMed ID: 3439403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.